We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Abzena | LSE:ABZA | London | Ordinary Share | GB00BN65QN46 | ORD GBP0.002 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 15.75 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
06/3/2017 12:29 | no idea what MRF is posting but hey 3 times on one day, must be bored... nice to see another update this am IMO and while this is obviously not without its risk, N1 reiterate the unchanged intrinsic value at c.93p...DYOR etc etc... Cheers | qs99 | |
02/3/2017 13:56 | Whahahawhahehe, wahaha | my retirement fund | |
02/3/2017 13:49 | You a funny onion. Q99Hahhahjahahaha | my retirement fund | |
01/3/2017 12:10 | looks like a bit of demand bubbling IMO | qs99 | |
01/3/2017 08:28 | and no I am invested because I like other people paying for my lifestyle....also feel sorry for you wasting your time on threads where you are not invested, surely you have better things to do, or maybe not....enjoy (filtered) | qs99 | |
01/3/2017 08:28 | nice little uptick | qs99 | |
22/2/2017 13:41 | Forgive my ignorance but i assumed you were invested here because you enjoy paying for other people's lifestyle.Hahahahaha | my retirement fund | |
21/2/2017 07:26 | Nice in line update and new agreement IMO....signalling new funding though it would appear to keep growth up....be interesting how that is seen by market....let's see.. | qs99 | |
03/2/2017 13:24 | Indeed, looks like sellers cleared IMO, bonkers after recent RNS and broker notes outlining value to be had here IMO. DYOR etc | qs99 | |
03/2/2017 11:58 | And a nice 90k buy just there. | x54v | |
03/2/2017 11:50 | Buyers starting to take advantage of the crazy recent dip. | x54v | |
31/1/2017 16:26 | Any idea which Bio/Pharma company it is.? Why haven't they named them.? | recordz | |
31/1/2017 16:24 | indeed, thanks for posting that. very interesting. still sellers out there though, been a week of solid selling, once these punters are gone, hopefully any further rise will be more sustainable....DYOR | qs99 | |
31/1/2017 16:13 | 75% ish held by II's. They tend to look long term. | recordz | |
31/1/2017 14:13 | Woodford a significant holder with 23% of the company: | x54v | |
31/1/2017 14:11 | just had a read, this and other broker note (DYOR) suggest this is delivering and IMO has been sold down post IPO unreasonably....more licensing deals this year if they happen or other positive news will IMO propel these sharply higher in short order as so tightly held....GLA and DYOr etc | qs99 | |
31/1/2017 13:54 | Especially given the recent news - $300 million potential vs. market cap of just £55m. Good entry point for those who missed buying the first time round. | x54v | |
31/1/2017 13:48 | yep the drop seemed overdone to me also | mister md | |
31/1/2017 13:47 | A flurry of buying on the back of the Hardman note. Plenty of buyers taking advantage of the bargain levels afforded by the crazy recent dip. | x54v | |
31/1/2017 12:58 | "The latest agreement for ThioBridge technology after extensive evaluation work provides further validation for the technology and has boosted market confidence that Abzena offers significant returns for investors." | x54v | |
31/1/2017 12:56 | Hardman research note just out: | x54v | |
28/1/2017 14:01 | Yeah it is over half the companies listed on am subject their shareholders time some kind of fraud from my observations.The companies you mention are an unquantifiable wreckless gamble though.Why not take a measured gamble that you can at least quantity the odds to some extent if you must have a high risk/reward aim addition to a balanced portfolio ?ASH for example ? | my retirement fund |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions